Gold nanoparticles functionalized with PD-L1 inhibitors, such as anti-PD-L1 antibodies or PD-L1-binding peptides, have been shown in preclinical studies to greatly increase CD8+ T-cell infiltration and improve tumor control when compared to free PD-L1 inhibitors [89]. Here, CD8A is linked to neoplasm.